NF Center Receives Department of Defense Clinical Trials Grant
The Washington University NF Center was awarded a grant from the Department of Defense to participate in the NF Clinical Trials Consortium. This consortium is composed of eleven clinical programs worldwide focused on evaluating promising new treatments for NF1 and NF2.
Coordinated by Dr. Bruce Korf at the University of Alabama – Birmingham, this large multi-center collaborative group aims to rapidly assess the effectiveness of novel therapies for bone abnormalities, brain tumors, plexiform neurofibromas, malignant peripheral nerve sheath tumors, and cognitive problems in children and adults with NF1 as well as brain tumors in individuals with NF2.
“The ability to evaluate promising new treatments in a rapid and efficient manner is a major advance for our families living with NF1 and NF2”, says Dr. David Gutmann, Director of the Washington University NF Center.